Cite

HARVARD Citation

    Yorozuya, T. et al. (2021). Repeated treatment with gefitinib and alectinib in a patient with multiple EGFR-mutant and ALK-mutant lung adenocarcinomas: A case report. Respiratory medicine case reports. p. . [Online]. 
  
Back to record